Funding

AI Healthtech Startup Dehaze Raises €3.2M Funding Led By YZR Capital

Apr 29, 2026 | By Team SR

dehaze, a Munich-based healthtech AI startup, has raised €3.2 million in a seed funding round led by YZR Capital and DN Capital, with participation from Angel Invest, Zoho, and Better Ventures.

SUMMARY

  • dehaze, a Munich-based healthtech AI startup, has raised €3.2 million in a seed funding round led by YZR Capital and DN Capital, with participation from Angel Invest, Zoho, and Better Ventures.

The funding will be used to develop a foundational AI model focused on detecting chronic diseases earlier.

The company’s platform uses causal AI to analyse large volumes of patient data, helping healthcare payers identify individuals at risk, improve treatment outcomes, and lower costs.

Chronic diseases are the leading cost driver in global healthcare, responsible for around 70% of deaths and over $8 trillion in annual spending, according to the World Health Organization. Despite the vast amount of health data available, clinicians often review only a small portion, which means many conditions go undetected in their early, more treatable stages.

Read Also - Always Friday Raises €1.05M To Automate Corporate Event Planning With AI

dehaze aims to bridge this gap with a purpose-built AI model tailored for healthcare data. Its system can process diverse datasets at scale and deliver causal insights to support decision-making for both clinicians and insurers helping enable earlier intervention and reduce overall healthcare costs.

The new funding will be used to expand both the technical and commercial teams and to further develop platform capabilities, including features for recommending next-best actions and improving traceability.

Marius Klages, co-founder and CEO of dehaze, said the company was built in Munich from the ground up as a foundational AI model for chronic disease detection, rather than as a chatbot or dashboard-style solution:

Our customers are global from day one, because the problem is global from day one. The speed at which payers are signing with us confirms what we believed when we started: this is a category that will be defined over the next few years, and dehaze is going to define it.

About dehaze

dehaze is a healthtech company focused on detecting chronic diseases before symptoms appear. Its mission is to enable early intervention helping patients avoid serious health impacts and improve quality of life. By using advanced AI, dehaze aims to make healthcare more proactive, efficient and data-driven for better long-term outcomes.

Recommended Stories for You